- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07704008
The Effect of Virtual Reality Glasses Applied to Hemodialysis Patients on Vital Signs and Anxiety Level
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
The research was designed and conducted as a randomized controlled experimental study to determine the effects of virtual reality glasses on the vital signs and anxiety levels of hemodialysis patients.
The study population consisted of patients diagnosed with kidney failure who received hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between May 2023 and May 2024. A total of 56 patients who volunteered to participate and met the inclusion criteria were included in the study. These patients were randomly assigned to two homogeneous groups according to gender and type of renal failure (acute/chronic): an experimental group (n=28) and a control group (n=28).
Patients in the experimental group watched a 4K virtual reality video featuring natural scenery accompanied by relaxing background music through virtual reality glasses during hemodialysis, whereas patients in the control group received standard hemodialysis care without any additional intervention.
Data were collected using the Patient Information Form, Vital Signs Follow-up Form, Visual Analog Scale for Pain (VAS), State Anxiety Scale, and Visual Analog Scale for Satisfaction (VAS-Satisfaction). Ethics committee approval, institutional permission, and written informed consent were obtained before the study was conducted.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Ankara, Turkije (Türkiye), 06200
- Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Receiving hemodialysis treatment for the first time.
- Age ≥18 years.
- No visual, hearing, or cognitive impairment.
- Able to communicate effectively.
- Clinically stable.
- No diagnosed psychiatric disorder or use of psychiatric medication.
- No history of seizures.
- Willing and able to provide informed consent.
Exclusion Criteria:
- Previous hemodialysis treatment.
- Age <18 years.
- Visual, hearing, or cognitive impairment.
- History of kidney transplantation.
- Communication difficulties.
- Diagnosed psychiatric disorder or use of psychiatric medication.
- History of seizures.
- Declined to participate in the study.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Experimental Group
Participants received a virtual reality intervention during hemodialysis in addition to standard care.
|
Participants wore virtual reality glasses at the start of the hemodialysis session and viewed a 4K nature video with calming background music for 15 minutes.
The intervention was administered once during the hemodialysis session in addition to standard hemodialysis care.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
|
|
Actieve vergelijker: Control Group
Participants received standard hemodialysis care without any additional intervention.
|
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Systolic Blood Pressure
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in systolic blood pressure measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Diastolic Blood Pressure
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in diastolic blood pressure measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Heart Rate
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in heart rate measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Respiratory Rate
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in respiratory rate measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Peripheral Oxygen Saturation (SpO₂)
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in peripheral oxygen saturation (SpO₂) measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Body Temperature
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in body temperature measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
State Anxiety Level After Hemodialysis
Tijdsspanne: Immediately after completion of the hemodialysis session.
|
State anxiety measured using the State Anxiety Inventory (STAI-State), a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater levels of state anxiety.
Assessment was performed immediately after completion of the hemodialysis session.
|
Immediately after completion of the hemodialysis session.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Pain Score
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in pain score measured using the Visual Analog Scale for Pain (VAS-P), a 0-10 scale where 0 indicates no pain and 10 indicates the worst possible pain.
Higher scores indicate greater pain.
Pain was assessed before and immediately after completion of the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Participant Satisfaction Score
Tijdsspanne: Immediately after completion of the hemodialysis session.
|
Participant satisfaction with the virtual reality intervention measured using the Visual Analog Scale for Satisfaction (VAS-S), a 0-10 scale where 0 indicates not satisfied at all and 10 indicates completely satisfied.
Higher scores indicate greater participant satisfaction.
Assessment was performed immediately after completion of the hemodialysis session.
|
Immediately after completion of the hemodialysis session.
|
Medewerkers en onderzoekers
Onderzoekers
- Studie directeur: Hilal Tüzer, Assoc. Prof., Ankara Yildirim Beyazıt University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- AYBU-2023-208
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .